Cargando…

1712. Reduction of Neonatal Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections After Implementation of a S. aureus Screening and Decolonization Protocol

BACKGROUND: Staphylococcus aureus (SA) is an endemic, clinically important organism in Neonatal Intensive Care Units (NICUs). An 86-bed level III NICU at an academic medical center saw an increase in patients with methicillin-susceptible SA (MSSA) bloodstream infections (BSIs) from October-December...

Descripción completa

Detalles Bibliográficos
Autores principales: Weber, Rachel, Wharry, Jeananne, Malczynski, Michael, Lehman, Jennifer, Caldarelli, Leslie, Bolon, Maureen K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677472/
http://dx.doi.org/10.1093/ofid/ofad500.1545
_version_ 1785150138055917568
author Weber, Rachel
Wharry, Jeananne
Malczynski, Michael
Lehman, Jennifer
Caldarelli, Leslie
Bolon, Maureen K
author_facet Weber, Rachel
Wharry, Jeananne
Malczynski, Michael
Lehman, Jennifer
Caldarelli, Leslie
Bolon, Maureen K
author_sort Weber, Rachel
collection PubMed
description BACKGROUND: Staphylococcus aureus (SA) is an endemic, clinically important organism in Neonatal Intensive Care Units (NICUs). An 86-bed level III NICU at an academic medical center saw an increase in patients with methicillin-susceptible SA (MSSA) bloodstream infections (BSIs) from October-December 2020, as well as a cluster of patients with MSSA skin infections associated with intravenous catheters, which led to the intervention described. METHODS: We created a multidisciplinary team and reviewed infection prevention measures in our NICU, national recommendations and published literature. Previous state, NICU patients were screened for methicillin-resistant SA (MRSA) on day of life 7 or upon admission from an outside hospital or home. On 11/1/2021, we implemented weekly screening cultures for MRSA and MSSA among all NICU patients, performed using a composite swab of the bilateral anterior nares, axilla, peri-umbilical area, and perianal area. Decolonization of SA-colonized patients was performed with mupirocin (MUP) and chlorhexidine gluconate (CHG) bathing. MUP was applied to nares twice per day for 5 days for all colonized patients and 5 days of CHG bathing was administered only to patients greater than 48 weeks postmenstrual age. Patients were decolonized up to 2 times. Incidence rates (IR) and incidence rate ratios (IRR) were calculated. RESULTS: Between 11/1/2021 – 1/30/23, 1186 unique patients were screened with 177 unique patients colonized with MSSA and 9 unique patients colonized with MRSA. Of those colonized with MSSA, 126 (71.2%) patients were treated, with 123/126 treated with MUP only and 3/126 treated with MUP and CHG. Table 1 describes SA outcomes in the 15 month pre- and post-intervention periods. In the post-intervention period we observed a 73% decrease in MSSA BSIs (IRR, 0.27, 95% CI (0.05, 1.03)). [Figure: see text] CONCLUSION: Implementation of a SA screening and decolonization protocol in our NICU resulted in a statistically non-significant decrease in MSSA BSIs. Future work will seek to identify risk factors for colonization, factors associated with successful decolonization and genomic sequencing of MSSA isolates to characterize the spread of MSSA among neonates. DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-10677472
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-106774722023-11-27 1712. Reduction of Neonatal Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections After Implementation of a S. aureus Screening and Decolonization Protocol Weber, Rachel Wharry, Jeananne Malczynski, Michael Lehman, Jennifer Caldarelli, Leslie Bolon, Maureen K Open Forum Infect Dis Abstract BACKGROUND: Staphylococcus aureus (SA) is an endemic, clinically important organism in Neonatal Intensive Care Units (NICUs). An 86-bed level III NICU at an academic medical center saw an increase in patients with methicillin-susceptible SA (MSSA) bloodstream infections (BSIs) from October-December 2020, as well as a cluster of patients with MSSA skin infections associated with intravenous catheters, which led to the intervention described. METHODS: We created a multidisciplinary team and reviewed infection prevention measures in our NICU, national recommendations and published literature. Previous state, NICU patients were screened for methicillin-resistant SA (MRSA) on day of life 7 or upon admission from an outside hospital or home. On 11/1/2021, we implemented weekly screening cultures for MRSA and MSSA among all NICU patients, performed using a composite swab of the bilateral anterior nares, axilla, peri-umbilical area, and perianal area. Decolonization of SA-colonized patients was performed with mupirocin (MUP) and chlorhexidine gluconate (CHG) bathing. MUP was applied to nares twice per day for 5 days for all colonized patients and 5 days of CHG bathing was administered only to patients greater than 48 weeks postmenstrual age. Patients were decolonized up to 2 times. Incidence rates (IR) and incidence rate ratios (IRR) were calculated. RESULTS: Between 11/1/2021 – 1/30/23, 1186 unique patients were screened with 177 unique patients colonized with MSSA and 9 unique patients colonized with MRSA. Of those colonized with MSSA, 126 (71.2%) patients were treated, with 123/126 treated with MUP only and 3/126 treated with MUP and CHG. Table 1 describes SA outcomes in the 15 month pre- and post-intervention periods. In the post-intervention period we observed a 73% decrease in MSSA BSIs (IRR, 0.27, 95% CI (0.05, 1.03)). [Figure: see text] CONCLUSION: Implementation of a SA screening and decolonization protocol in our NICU resulted in a statistically non-significant decrease in MSSA BSIs. Future work will seek to identify risk factors for colonization, factors associated with successful decolonization and genomic sequencing of MSSA isolates to characterize the spread of MSSA among neonates. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2023-11-27 /pmc/articles/PMC10677472/ http://dx.doi.org/10.1093/ofid/ofad500.1545 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Weber, Rachel
Wharry, Jeananne
Malczynski, Michael
Lehman, Jennifer
Caldarelli, Leslie
Bolon, Maureen K
1712. Reduction of Neonatal Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections After Implementation of a S. aureus Screening and Decolonization Protocol
title 1712. Reduction of Neonatal Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections After Implementation of a S. aureus Screening and Decolonization Protocol
title_full 1712. Reduction of Neonatal Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections After Implementation of a S. aureus Screening and Decolonization Protocol
title_fullStr 1712. Reduction of Neonatal Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections After Implementation of a S. aureus Screening and Decolonization Protocol
title_full_unstemmed 1712. Reduction of Neonatal Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections After Implementation of a S. aureus Screening and Decolonization Protocol
title_short 1712. Reduction of Neonatal Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections After Implementation of a S. aureus Screening and Decolonization Protocol
title_sort 1712. reduction of neonatal methicillin-susceptible staphylococcus aureus bloodstream infections after implementation of a s. aureus screening and decolonization protocol
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677472/
http://dx.doi.org/10.1093/ofid/ofad500.1545
work_keys_str_mv AT weberrachel 1712reductionofneonatalmethicillinsusceptiblestaphylococcusaureusbloodstreaminfectionsafterimplementationofasaureusscreeninganddecolonizationprotocol
AT wharryjeananne 1712reductionofneonatalmethicillinsusceptiblestaphylococcusaureusbloodstreaminfectionsafterimplementationofasaureusscreeninganddecolonizationprotocol
AT malczynskimichael 1712reductionofneonatalmethicillinsusceptiblestaphylococcusaureusbloodstreaminfectionsafterimplementationofasaureusscreeninganddecolonizationprotocol
AT lehmanjennifer 1712reductionofneonatalmethicillinsusceptiblestaphylococcusaureusbloodstreaminfectionsafterimplementationofasaureusscreeninganddecolonizationprotocol
AT caldarellileslie 1712reductionofneonatalmethicillinsusceptiblestaphylococcusaureusbloodstreaminfectionsafterimplementationofasaureusscreeninganddecolonizationprotocol
AT bolonmaureenk 1712reductionofneonatalmethicillinsusceptiblestaphylococcusaureusbloodstreaminfectionsafterimplementationofasaureusscreeninganddecolonizationprotocol